Do not use Molnupiravur, Favipiravir, Azithromycin, Doxycycline, Ivermectin etc in COVID-19: ICMR revised guidelines Dr. Nandita Mohan20 March 2023 11:40 AM GMTWith a sudden spurt in COVID-19 cases across various parts of the country, the Indian Council of Medical Research (ICMR), the leading body for medical...
Health Bulletin 20/March/2023 Dr. Nandita Mohan20 March 2023 10:44 AM GMTHere are the top health stories for the day:NCDRC holds no medical negligence, relief of Rs 17 lakh to orthopaedic surgeon, nursing homeThe National...
FIRST: Hetero wins WHO Prequalification for generic version of Pfizer COVID drug Paxlovid Ruchika Sharma26 Dec 2022 10:45 AM GMTThe combi pack, launched by Hetero as NIRMACOM, will contain nirmatrelvir 150 mg (2 tablets) and ritonavir 100mg (1 tablet).
Medical Bulletin 16/December/2022 Isra Zaman16 Dec 2022 9:00 AM GMTHere are the top medical news for the day:Antibiotic resistance may be overcome by mapping E.coliHave you ever felt queasy after eating an undercooked...
Antiviral drug nirmatrelvir plus ritonavir effective in reducing COVID-19 hospitalization among vaccinated adults 50 and over Isra Zaman16 Dec 2022 4:00 AM GMTThe results of recent clinical trial, now published in Annals of Internal Medicine, suggest that the antiviral drug nirmatrelvir plus ritonavir...
NPPA revises retail price of Emcure Pharma Darunavir, Ritonavir FDC Farhat Nasim3 Nov 2022 12:30 PM GMTNew Delhi: The National Pharmaceuticals Pricing Authority (NPPA) has revised the retail price of Emcure Pharmaceuticals Ltd's cocktail formulation of...
Cipla, DNDi unveil 4-in-1 ARV formulation for kids with HIV Ruchika Sharma15 Jun 2022 6:30 AM GMTThe '4-in-1' combination contains an antiretroviral combination that is recommended by the World Health Organization (WHO) as an alternative...
Pfizer COVID drug Paxlovid strongly recommended by WHO Ruchika Sharma22 April 2022 8:02 AM GMTThe WHO recommended Paxlovid over remdesivir, as well as over Merck's molnupiravir pill and monoclonal antibodies.
Granules India Receives Licences from MPP to Market generic of Pfizers Paxlovid MD Bureau21 March 2022 6:16 AM GMTThe product will be made at Granules manufacturing facilities in India that are approved by global regulatory agencies including USFDA. The license...
Novel Antiviral Shows Promising Results Against COVID -19 MD Bureau21 Feb 2022 3:30 AM GMTInfection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and illness with the associated coronavirus disease 2019 (Covid-19)...
Pfizer gets CDSCO panel nod to study PF-07321332 for COVID treatment Medical Dialogues Team26 Nov 2021 1:39 PM GMTNew Delhi: In a significant development, pharmaceutical major Pfizer has got a go ahead from the Subject Expert Committee (SEC) of the Central Drugs...
Pfizer, Medicines Patent Pool ink pact to expand Covid-19 oral antiviral treatment access Ruchika Sharma17 Nov 2021 5:30 AM GMTNew York: Pfizer Inc. and the Medicines Patent Pool (MPP), have recently announced the signing of a voluntary license agreement for Pfizer's...
